Naprius (Naproxen)

Naproxen works by reversibly inhibiting the cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which are essential for prostaglandin production. Lower prostaglandin levels reduce the inflammatory response, diminish pain signaling, and lower body temperature when fever is present.

The appropriate dose of Naprius is determined by the prescribing healthcare professional based on the individual’s condition, age, weight, and response to therapy. Patients should follow the prescriber’s instructions and not exceed the recommended amount.

Safety of naproxen during pregnancy and lactation depends on the trimester and clinical circumstances. It is generally avoided in the third trimester and used only if the benefit outweighs the risk. Breastfeeding mothers should consult their physician, as naproxen can be excreted in milk.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Naprius (naproxen) has a longer half‑life than ibuprofen, allowing less frequent dosing for some patients. Compared with selective COX‑2 inhibitors, naproxen offers a broader anti‑inflammatory effect but may carry a higher risk of gastrointestinal irritation. Choice of NSAID should be individualized based on efficacy, safety profile, and patient comorbidities.

Naprius should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture, direct sunlight, and excessive heat to maintain stability and potency.

Naprius is taken orally, usually with a full glass of water. It can be taken with or without food, though taking it with food may reduce gastrointestinal discomfort. Patients should swallow tablets whole and not crush or chew them unless instructed otherwise.

Serious risks include gastrointestinal ulceration or bleeding, acute kidney injury, and severe hypersensitivity reactions such as Stevens‑Johnson syndrome or toxic epidermal necrolysis. Patients should seek immediate medical attention if they experience black stools, severe abdominal pain, sudden swelling, or skin rash.

Naprius should be avoided in individuals with known hypersensitivity to naproxen or other NSAIDs, active gastrointestinal ulcer or bleeding, severe heart failure, and in the third trimester of pregnancy. It is also contraindicated in patients with significant renal impairment unless specifically directed by a physician.